All Industry News articles
-
CareersThe Future is Fungi 2025: award-winner Michroma’s mission to harness fungi for clean food dyes and flavors
Winner of The Future is Fungi Award 2025, US and Argentina-based foodtech startup Michroma is replacing petrochemical coloring with fungibased natural ingredients, launching one of the world’s leading sustainable platforms for food flavors and colors. Here’s its story.
-
NewsApriori Bio and A*STAR Infectious Diseases Labs Announce strategic partnership to advance next generation influenza vaccines
Apriori Bio and the Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) announced a strategic research partnership to co-develop and evaluate next generation self-amplifying RNA (saRNA) vaccines targeting seasonal and pandemic influenza.
-
NewsTyphoid conjugate vaccine demonstrates strong safety and immunogenicity: Results from Phase 3 study
PATH and EuBiologics Co., LTD have announced Phase 3 results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj.® Multi-dose. EuTYPH-C Inj.® Source: CDC/ Armed Forces Institute of Pathology, Charles N. Farmer This photomicrograph reveals some of the histopathology exhibited in a lymph node tissue ...
-
NewsCARBIOS and Wankai New Materials to build PET biorecycling plant in China
CARBIOS and Wankai New Materials, a subsidiary of Zhink Group, are committed to the large-scale deployment of CARBIOS’ PET biorecycling technology in Asia, with the first step being the construction of a PET biorecycling plant in China.
-
NewsUK’s failure to retain and scale science and technology causing economy to bleed out, warns Lords Committee
The UK’s failure to retain and scale its science and technology companies has now reached crisis point and is causing the UK economy to bleed out, warns a damning report.
-
NewsBruker announces FDA Clearance of Claims 7 and 8 for the MALDI Biotyper® CA System
Bruker has announced FDA clearance of Claim 7 and Claim 8 for its MALDI Biotyper® CA System, marking a significant advancement in clinical microbial identification capabilities.
-
NewsPioneering gut health testing with a simple finger prick
Zinzino, the Scandinavian health and wellness company, has announced the launch of its innovative Gut Health Test. With a simple at-home finger prick, this is the first commercial test to measure what gut bacteria produce and how the body responds.
-
NewsCaldic and AmphiStar join forces to transform personal care market in Europe with upcycled microbial biosurfactants
Global distributor Caldic and Belgian biotech innovator AmphiStar have announced an exclusive partnership to distribute and promote AmphiStar’s 100% upcycled microbial biosurfactants for personal care applications across Europe.
-
News Bioinsecticide start-up BugBiome focuses on lead product development with move to Norwich Research Park
BugBiome, the agri-tech innovator developing new bioinsecticides from crop-associated microbes, has relocated to Norwich Research Park as it focuses on moving its lead aphicide into field trials in 2026.
-
NewsMolecular Sustainable Solutions receives investment from BeAble Capital to boost disinfection and sterilization methods
Molecular Sustainable Solutions, a spin-off from the Universitat Jaume I of Castelló (UJI), secures €186,000 investment from BeAble Capital, a leading Science Equity fund specializing in disruptive scientific technologies.
-
NewsCARB-X to support lower respiratory tract infection diagnostic by Zeteo
CARB-X has awarded Zeteo Tech, Inc. US$1M to execute a workplan for its noninvasive diagnostic platform that aims to evaluate whether exhaled breath can diagnose lower respiratory tract infections (LRTIs) in high-risk populations within critical care environments.
-
News CRISPR-based therapeutics hold potential to combat AMR and cure chronic viral infections, says GlobalData
CRISPR-based therapeutics show potential to combat antimicrobial resistance (AMR) and deliver functional cures for chronic viral infections, says GlobalData, a leading data and analytics company.
-
NewsAI poised to revolutionize Lyme disease testing and treatment
Researchers unveiled a blood test developed with the help of artificial intelligence (AI) that identifies Lyme disease sooner and more accurately than the current standard — and that could translate to vastly improved patient outcomes.
-
NewsFlightpath Biosciences licenses microbiome-sparing antibiotic developed at Illinois
Flightpath Biosciences, Inc., has licensed a class of antibiotics developed at the University of Illinois Urbana-Champaign. The original antibiotic agent, lolamicin, effectively treated bacterial infections in animal models of disease without wiping out beneficial gut microbes.
-
News BugBiome to test lead bioinsecticide in sugar beet field trials with partner Niab
BugBiome, an agritech innovator developing new bioinsecticides from crop-associated microbes, is field testing its lead product against aphids via a new Innovate UK grant with partner Niab, an experienced crop trial specialist.
-
NewsAFYREN begins new phase of industrial strategy as first plant AFYREN NEOXY achieves continuous production
Greentech company AFYREN offering industrial customers bio-based, low-carbon products through fermentation technology based on a circular model, announced its first plant has achieved continuous production, enabling acceleration of commercialization.
-
NewsSmart plastics are key to curbing healthcare infection rates, says Symphony Environmental
A leading plastics innovator urges hospitals and care-homes to adopt antimicrobial smart plastic solutions to address infection rates.
-
NewsTransatlantic collaboration to develop therapeutic for Crimean-Congo Hemorrhagic Fever
A new transatlantic collaboration will look to develop an affordable and accessible monoclonal antibody therapeutic for Crimean-Congo Hemorrhagic Fever Virus (CCHFV), which could treat and protect thousands of people globally.
-
NewsAFYREN strengthens its Executive Committee with appointment of Laurent Pou as Industrial Director
AFYREN, a greentech company offering manufacturers biobased, low-carbon ingredients through a unique fermentation technology based on a circular model, has announced the appointment of Laurent Pou as Industrial Director.
-
NewsPhage therapy at a crossroads: global experts gather for ground-breaking 2025 Congress
Global multidisciplinary experts and innovators convene for the 8th World Congress on Targeting Phage Therapy 2025 on June 10-11. This leading event is dedicated to the advancement of bacteriophage science and applications in multiple bioscience areas.